Persistent Systems announced its financial results for the first quarter of FY27, reporting a 16.1% year-over-year increase in revenue, reaching $452.4 million. The company also achieved an EBIT margin of 16.0%. This performance was supported by strong growth in Total Contract Value (TCV) and continued momentum in client engagements.
Persistent Systems Reports Strong Q1 FY27 Performance
Persistent Systems has released its financial highlights for the first quarter of Fiscal Year 2027 (Q1 FY27), demonstrating robust growth and profitability. The company marked its 25th sequential quarter of revenue growth, beginning FY27 with a 3.8% quarter-over-quarter increase and a significant 16.1% year-over-year revenue growth, totaling $452.4 million. This performance was complemented by an impressive EBIT margin of 16.0%.
Key Financial Drivers
This strong financial outcome was underpinned by a record quarterly Total Contract Value (TCV) of $1.15 billion. This reflects sustained momentum in larger client engagements, including a 6.5-year strategic services agreement with a leading global technology company, valued at over $650 million.
Strategic Initiatives and Outlook
Persistent Systems also highlighted its strategic direction, including the signing of a Business Combination Agreement with Nagarro, a European digital engineering company. This move aligns with the company’s M&A strategy to enhance capabilities and expand geographic and industry coverage. The company emphasized its focus on creating a unified Enterprise Context for clients leveraging AI, supported by its 3C framework and AI-driven platforms.
Financial Snapshot (Q1 FY27)
Revenue
Revenue from Operations (USD Million): $452.4
YoY Growth: 16.1%
Revenue from Operations (INR Million): 43,032.3
YoY Growth: 29.1%
Profitability
EBIT (INR Million): 6,868.8
EBIT Margin: 16.0%
PAT (INR Million): 4,830.4
PAT Margin: 11.2%
TTM Performance
Trailing Twelve Months (TTM) Revenue ($ Million): $1,717.1 (16.8% growth)
TTM EBIT ($ Million): 24,725.3 (31.2% growth)
TCV and ACV Bookings
Trailing Twelve Months TCV*: $3,030.7 Million
Trailing Twelve Months ACV*: $1,931.7 Million
*Includes renewals & new bookings.
Segment Revenue Mix
BFSI
34.0%
Healthcare & Life Sciences
25.3%
Software, Hi-Tech & Emerging Industries
40.7%
Geography Revenue Mix
North America
79.1%
Europe
8.5%
India
9.8%
ROW
2.6%
Source: BSE
